Jan H Kleibeuker
Overview
Explore the profile of Jan H Kleibeuker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hennink S, van der Meulen-de Jong A, Wolterbeek R, Crobach A, Becx M, Crobach W, et al.
J Clin Oncol
. 2015 Nov;
33(35):4188-93.
PMID: 26527788
Purpose: Colonoscopic surveillance is recommended for individuals with familial colorectal cancer (CRC). However, the appropriate screening interval has not yet been determined. The aim of this randomized trial was to...
12.
Honing J, Pavlov K, Mul V, Karrenbeld A, Meijer C, Faiz Z, et al.
Radiother Oncol
. 2015 Sep;
117(1):152-8.
PMID: 26364884
Background And Purpose: Neoadjuvant chemoradiotherapy (nCRT) improves survival in esophageal cancer (EC) patients, but the response to treatment is heterogeneous and little is known regarding prognostic and predictive markers in...
13.
Buurman D, de Monchy J, Schellekens R, van der Waaij L, Kleibeuker J, Dijkstra G
Scand J Gastroenterol
. 2015 Jan;
50(4):399-405.
PMID: 25633468
Background And Aims: Mesalazine is a key drug in the treatment of ulcerative colitis (UC). Intolerance to mesalazine has been described, including fever and gastrointestinal symptoms. Several case reports reported...
14.
van Heijningen E, Lansdorp-Vogelaar I, Steyerberg E, Goede S, Dekker E, Lesterhuis W, et al.
Gut
. 2015 Jan;
64(10):1584-92.
PMID: 25586057
Objective: To determine adherence to recommended surveillance intervals in clinical practice. Design: 2997 successive patients with a first adenoma diagnosis (57% male, mean age 59 years) from 10 hospitals, who...
15.
Pavlov K, Honing J, Meijer C, Boersma-van Ek W, Peters F, van den Berg A, et al.
Dig Liver Dis
. 2014 Dec;
47(1):73-80.
PMID: 25445407
Background: Barrett's oesophagus can progress towards oesophageal adenocarcinoma through a metaplasia-dysplasia-carcinoma sequence, but the underlying mechanisms are poorly understood. The transcription factor GATA6 is known to be involved in columnar...
16.
Haanstra J, Al-Toma A, Dekker E, Vanhoutvin S, Nagengast F, Mathus-Vliegen E, et al.
Gut
. 2014 Sep;
64(10):1578-83.
PMID: 25209657
Objective: The aim was to determine the prevalence of small-bowel neoplasia in asymptomatic patients with Lynch syndrome (LS) by video capsule endoscopy (VCE). Design: After obtaining informed consent, asymptomatic proven...
17.
Jung A, van Duijnhoven F, Nagengast F, Botma A, Heine-Broring R, Kleibeuker J, et al.
Cancer Causes Control
. 2014 Jun;
25(9):1119-29.
PMID: 24916333
Purpose: Dietary intake of B vitamins and methionine, essential components of DNA synthesis and methylation pathways, may influence colorectal tumor (CRT) development. The impact of B vitamins on colorectal carcinogenesis...
18.
Heine-Broring R, Winkels R, Botma A, van Duijnhoven F, Jung A, Kleibeuker J, et al.
PLoS One
. 2013 Jul;
8(6):e66819.
PMID: 23825568
Background And Aims: Individuals with Lynch syndrome have a high lifetime risk of developing colorectal tumors. In this prospective cohort study of individuals with Lynch syndrome, we examined associations between...
19.
van Heijningen E, Lansdorp-Vogelaar I, Kuipers E, Dekker E, Lesterhuis W, Borg F, et al.
Gastroenterology
. 2013 Mar;
144(7):1410-8.
PMID: 23499951
Background & Aims: We investigated adenoma and colonoscopy characteristics that are associated with recurrent colorectal neoplasia based on data from community-based surveillance practice. Methods: We analyzed data of 2990 consecutive...
20.
Haanstra J, Kleibeuker J, Koornstra J
Fam Cancer
. 2013 Feb;
12(2):267-72.
PMID: 23420551
Lynch syndrome, or hereditary nonpolyposis colorectal cancer (HNPCC), is the most common hereditary condition predisposing for colorectal cancer. International guidelines recommend surveillance of the colorectum by colonoscopy every 1-2 years...